Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    "hemochromatosis"
Show Display Options
Download search resultsDownload the search results for:
"hemochromatosis" (39 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
Intervention:
2 Recruiting Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
Condition: Hemochromatosis Type 1
Intervention: Procedure: First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
3 Unknown  Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
Condition: Hemochromatosis
Interventions: Procedure: Arm 1: Erythrocyte apheresis;   Procedure: Arm 2: Whole blood phlebotomy
4 Completed Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
Condition: Genetic Hemochromatosis
Intervention:
5 Active, not recruiting Cardiac Function in Patients With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention:
6 Completed Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
Condition: Hemochromatosis
Interventions: Procedure: Phlebotomy;   Procedure: Erythrocytapheresis
7 Unknown  Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
Condition: Hereditary Hemochromatosis
Intervention: Other: Phlebotomy and erythrocytapheresis
8 Unknown  Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention: Drug: Pantoprazole
9 Completed HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
Intervention:
10 Completed Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
Condition: Hereditary Hemochromatosis
Intervention: Procedure: Eritrocytoapheresis
11 Unknown  Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis
Condition: Hereditary Haemochromatosis
Intervention: Other: Interviews, questionaires, RAND-modified delphi method round
12 Recruiting Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
Condition: Refractory Hemochromatosis Rheumatism
Intervention: Drug: Anakinra
13 Completed
Has Results
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Conditions: Iron Overload;   Hereditary Hemochromatosis
Intervention: Drug: Deferasirox (ICL670)
14 Recruiting Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis
Conditions: Myocardial Iron Overload;   HFE-Associated Hereditary Hemochromatosis
Interventions: Device: 3Tesla cardiac MRI;   Device: Electrocardiogram (EKG);   Biological: Iron and cardiac markers;   Biological: Pregnancy test;   Device: Echocardiography at rest;   Biological: Urinary pregnancy test;   Device: 3Tesla abdominal MRI
15 Unknown  Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
Conditions: Hemochromatosis;   Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Other: Venesection
16 Completed Evaluation of a New MR Pulse Sequence to Quantify Liver Iron Concentration
Condition: Hemochromatosis
Intervention:
17 Completed Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine
18 Completed Hemochromatosis--Genetic Prevalence and Penetrance
Conditions: Blood Disease;   Hemochromatosis
Intervention:
19 Completed Statistical Basis for Hemochromatosis Screening
Conditions: Blood Disease;   Hemochromatosis
Intervention:
20 Completed Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients
Condition: Hemochromatosis
Interventions: Drug: Deferiprone (L1);   Drug: Desferrioxamine

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.